BIOMAT Database Logo BIOMAT Database Logo

[Endocrine hypertension in primary aldosteronism and in Cushing's syndrome]. 1976

W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007008 Hypokalemia Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed) Hypopotassemia,Hypokalemias,Hypopotassemias
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
The kidney in endocrine hypertension. Cushing's syndrome, pheochromocytoma, and aldosteronism.
April 1970, Archives of surgery (Chicago, Ill. : 1960),
W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
Postoperative improvement of hypertension in primary aldosteronism and Cushing's syndrome.
January 1975, Urologia internationalis,
W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
Endocrine hypertension - Cushing's syndrome.
October 2011, Indian journal of endocrinology and metabolism,
W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
[Cardiovascular changes in Cushing's syndrome and primary aldosteronism].
January 1996, Ryoikibetsu shokogun shirizu,
W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
[Malignant hypertension in primary aldosteronism syndrome].
January 1978, Wiadomosci lekarskie (Warsaw, Poland : 1960),
W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
January 2021, Frontiers in endocrinology,
W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
Laparoscopic adrenalectomy for Cushing's syndrome: comparison with primary aldosteronism.
January 1995, Surgery,
W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
[Clinical Evaluation of Primary Aldosteronism with Subclinical Cushing's Syndrome].
May 2015, Hinyokika kiyo. Acta urologica Japonica,
W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
Pregnancy induced Cushing's syndrome and primary aldosteronism: a case report.
July 2020, BMC pregnancy and childbirth,
W Vetter, and H Vetter, and R Beckerhoff, and F Wittassek, and G Pouliadis, and J Furrer, and W Siegenthaler
[How to screen for pheochromocytoma, primary aldosteronism and Cushing's syndrome].
January 2009, Revue medicale suisse,
Copied contents to your clipboard!